MAPT and behavioral variant of frontotemporal dementia: The most studied biomarkers in the cerebrospinal fluid (CSF) of bvFTD patients have been phospho-tau, total tau, amyloid-β1–42 (and their ratios), and, more recently, neuronal cytoskeletal protein neurofilament light chain (NfL).